29.2 USD
-0.46 (-1.55%)
Overall TCMD gets a fundamental rating of 6 out of 10. We evaluated TCMD against 186 industry peers in the Health Care Equipment & Supplies industry. While TCMD has a great health rating, its profitability is only average at the moment. TCMD is growing strongly while it is still valued neutral. This is a good combination! This makes TCMD very considerable for growth investing!
1. Profitability
1.1 Basic Checks
In the past year TCMD was profitable.
TCMD had a positive operating cash flow in the past year.
In multiple years TCMD reported negative net income over the last 5 years.
In the past 5 years TCMD always reported a positive cash flow from operatings.
1.2 Ratios
Looking at the Return On Assets, with a value of 7.01%, TCMD belongs to the top of the industry, outperforming 88.17% of the companies in the same industry.
Looking at the Return On Equity, with a value of 8.86%, TCMD belongs to the top of the industry, outperforming 82.26% of the companies in the same industry.
TCMD has a Return On Invested Capital of 7.56%. This is amongst the best in the industry. TCMD outperforms 82.80% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.01% | ||
| ROE | 8.86% | ||
| ROIC | 7.56% |
ROA(3y)2.94%
ROA(5y)0.73%
ROE(3y)2.6%
ROE(5y)-0.37%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
The Profit Margin of TCMD (5.83%) is better than 78.49% of its industry peers.
TCMD's Profit Margin has been stable in the last couple of years.
With a decent Operating Margin value of 7.39%, TCMD is doing good in the industry, outperforming 73.12% of the companies in the same industry.
In the last couple of years the Operating Margin of TCMD has grown nicely.
Looking at the Gross Margin, with a value of 49.88%, TCMD is in line with its industry, outperforming 44.09% of the companies in the same industry.
TCMD's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 7.39% | ||
| PM (TTM) | 5.83% | ||
| GM | 49.88% |
OM growth 3YN/A
OM growth 5Y6.44%
PM growth 3YN/A
PM growth 5Y-0.06%
GM growth 3Y3.35%
GM growth 5Y-0.43%
2. Health
2.1 Basic Checks
TCMD has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
TCMD has more shares outstanding than it did 1 year ago.
TCMD has more shares outstanding than it did 5 years ago.
TCMD has a better debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 9.54 indicates that TCMD is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 9.54, TCMD belongs to the top of the industry, outperforming 89.78% of the companies in the same industry.
There is no outstanding debt for TCMD. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 9.54 |
ROIC/WACC0.87
WACC8.65%
2.3 Liquidity
A Current Ratio of 3.61 indicates that TCMD has no problem at all paying its short term obligations.
TCMD has a Current ratio of 3.61. This is in the better half of the industry: TCMD outperforms 62.90% of its industry peers.
A Quick Ratio of 3.20 indicates that TCMD has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 3.20, TCMD is in the better half of the industry, outperforming 67.74% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.61 | ||
| Quick Ratio | 3.2 |
3. Growth
3.1 Past
TCMD shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 16.67%, which is quite good.
The Earnings Per Share has been growing slightly by 4.86% on average over the past years.
Looking at the last year, TCMD shows a quite strong growth in Revenue. The Revenue has grown by 9.28% in the last year.
TCMD shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 9.11% yearly.
EPS 1Y (TTM)16.67%
EPS 3YN/A
EPS 5Y4.86%
EPS Q2Q%71.43%
Revenue 1Y (TTM)9.28%
Revenue growth 3Y12.08%
Revenue growth 5Y9.11%
Sales Q2Q%17.32%
3.2 Future
Based on estimates for the next years, TCMD will show a very strong growth in Earnings Per Share. The EPS will grow by 20.90% on average per year.
The Revenue is expected to grow by 8.94% on average over the next years. This is quite good.
EPS Next Y14.64%
EPS Next 2Y19.86%
EPS Next 3Y20.9%
EPS Next 5YN/A
Revenue Next Year9.19%
Revenue Next 2Y9.01%
Revenue Next 3Y8.94%
Revenue Next 5YN/A
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 37.92, TCMD can be considered very expensive at the moment.
TCMD's Price/Earnings ratio is a bit cheaper when compared to the industry. TCMD is cheaper than 70.43% of the companies in the same industry.
When comparing the Price/Earnings ratio of TCMD to the average of the S&P500 Index (26.92), we can say TCMD is valued slightly more expensively.
The Price/Forward Earnings ratio is 28.63, which means the current valuation is very expensive for TCMD.
Based on the Price/Forward Earnings ratio, TCMD is valued a bit cheaper than the industry average as 72.58% of the companies are valued more expensively.
TCMD's Price/Forward Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 23.46.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 37.92 | ||
| Fwd PE | 28.63 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, TCMD is valued a bit cheaper than 78.49% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of TCMD indicates a rather cheap valuation: TCMD is cheaper than 93.01% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 16.56 | ||
| EV/EBITDA | 19.05 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The decent profitability rating of TCMD may justify a higher PE ratio.
A more expensive valuation may be justified as TCMD's earnings are expected to grow with 20.90% in the coming years.
PEG (NY)2.59
PEG (5Y)7.8
EPS Next 2Y19.86%
EPS Next 3Y20.9%
5. Dividend
5.1 Amount
TCMD does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
NASDAQ:TCMD (12/29/2025, 2:16:13 PM)
29.2
-0.46 (-1.55%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners98.46%
Inst Owner Change-2.68%
Ins Owners2.66%
Ins Owner Change-0.47%
Market Cap652.33M
Revenue(TTM)311.51M
Net Income(TTM)18.17M
Analysts81.82
Price Target24.48 (-16.16%)
Short Float %8.55%
Short Ratio4.16
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)64.96%
Min EPS beat(2)27.09%
Max EPS beat(2)102.84%
EPS beat(4)3
Avg EPS beat(4)18.21%
Min EPS beat(4)-82.07%
Max EPS beat(4)102.84%
EPS beat(8)7
Avg EPS beat(8)30.85%
EPS beat(12)11
Avg EPS beat(12)304.86%
EPS beat(16)11
Avg EPS beat(16)169.54%
Revenue beat(2)2
Avg Revenue beat(2)5.32%
Min Revenue beat(2)4.63%
Max Revenue beat(2)6.01%
Revenue beat(4)2
Avg Revenue beat(4)0.95%
Min Revenue beat(4)-5.08%
Max Revenue beat(4)6.01%
Revenue beat(8)3
Avg Revenue beat(8)-0.62%
Revenue beat(12)6
Avg Revenue beat(12)0.51%
Revenue beat(16)10
Avg Revenue beat(16)1.53%
PT rev (1m)0%
PT rev (3m)77.78%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)29.13%
EPS NY rev (3m)28.19%
Revenue NQ rev (1m)0.41%
Revenue NQ rev (3m)0.99%
Revenue NY rev (1m)2.44%
Revenue NY rev (3m)2.32%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 37.92 | ||
| Fwd PE | 28.63 | ||
| P/S | 2.09 | ||
| P/FCF | 16.56 | ||
| P/OCF | 15.59 | ||
| P/B | 3.18 | ||
| P/tB | 4.87 | ||
| EV/EBITDA | 19.05 |
EPS(TTM)0.77
EY2.64%
EPS(NY)1.02
Fwd EY3.49%
FCF(TTM)1.76
FCFY6.04%
OCF(TTM)1.87
OCFY6.42%
SpS13.94
BVpS9.17
TBVpS5.99
PEG (NY)2.59
PEG (5Y)7.8
Graham Number12.61
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.01% | ||
| ROE | 8.86% | ||
| ROCE | 10.46% | ||
| ROIC | 7.56% | ||
| ROICexc | 11.94% | ||
| ROICexgc | 24.41% | ||
| OM | 7.39% | ||
| PM (TTM) | 5.83% | ||
| GM | 49.88% | ||
| FCFM | 12.65% |
ROA(3y)2.94%
ROA(5y)0.73%
ROE(3y)2.6%
ROE(5y)-0.37%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5Y15.26%
ROICexc growth 3YN/A
ROICexc growth 5Y1.86%
OM growth 3YN/A
OM growth 5Y6.44%
PM growth 3YN/A
PM growth 5Y-0.06%
GM growth 3Y3.35%
GM growth 5Y-0.43%
F-Score7
Asset Turnover1.2
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 36.37% | ||
| Cap/Sales | 0.79% | ||
| Interest Coverage | 17.31 | ||
| Cash Conversion | 140.64% | ||
| Profit Quality | 216.85% | ||
| Current Ratio | 3.61 | ||
| Quick Ratio | 3.2 | ||
| Altman-Z | 9.54 |
F-Score7
WACC8.65%
ROIC/WACC0.87
Cap/Depr(3y)35.17%
Cap/Depr(5y)50.34%
Cap/Sales(3y)0.85%
Cap/Sales(5y)0.98%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)16.67%
EPS 3YN/A
EPS 5Y4.86%
EPS Q2Q%71.43%
EPS Next Y14.64%
EPS Next 2Y19.86%
EPS Next 3Y20.9%
EPS Next 5YN/A
Revenue 1Y (TTM)9.28%
Revenue growth 3Y12.08%
Revenue growth 5Y9.11%
Sales Q2Q%17.32%
Revenue Next Year9.19%
Revenue Next 2Y9.01%
Revenue Next 3Y8.94%
Revenue Next 5YN/A
EBIT growth 1Y7.23%
EBIT growth 3YN/A
EBIT growth 5Y16.13%
EBIT Next Year85.47%
EBIT Next 3Y35.54%
EBIT Next 5YN/A
FCF growth 1Y99.58%
FCF growth 3Y420.83%
FCF growth 5YN/A
OCF growth 1Y95.92%
OCF growth 3Y149.11%
OCF growth 5Y74.54%
TACTILE SYSTEMS TECHNOLOGY I / TCMD FAQ
Can you provide the ChartMill fundamental rating for TACTILE SYSTEMS TECHNOLOGY I?
ChartMill assigns a fundamental rating of 6 / 10 to TCMD.
What is the valuation status for TCMD stock?
ChartMill assigns a valuation rating of 4 / 10 to TACTILE SYSTEMS TECHNOLOGY I (TCMD). This can be considered as Fairly Valued.
What is the profitability of TCMD stock?
TACTILE SYSTEMS TECHNOLOGY I (TCMD) has a profitability rating of 6 / 10.
What are the PE and PB ratios of TACTILE SYSTEMS TECHNOLOGY I (TCMD) stock?
The Price/Earnings (PE) ratio for TACTILE SYSTEMS TECHNOLOGY I (TCMD) is 37.92 and the Price/Book (PB) ratio is 3.18.
Can you provide the financial health for TCMD stock?
The financial health rating of TACTILE SYSTEMS TECHNOLOGY I (TCMD) is 8 / 10.